Identification of Novel Cholesteatoma-Related Gene Expression Signatures Using Full-Genome Microarrays

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Klenke, Christin ^a   Janowski, Sebastian ^b   Borck, Daniela ^b   Widera, Darius ^b   Ebmeyer, Jörg ^a   Kalinowski, Jörn ^b   Leichtle, Anke ^a   Hofestädt, Ralf ^b   Upile, Tahwinder ^c   Kaltschmidt, Christian ^b   Kaltschmidt, Barbara ^b   Sudhoff, Holger ^a  

^a Klinikum Bielefeld   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CONNEXIN 26; CYTOKERATIN 19; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PROTEIN S 100; SERINE PROTEINASE INHIBITOR; SERPINB3; SERPINB4; UNCLASSIFIED DRUG;

ARTICLE; CANCER THERAPY; CDH19 GENE; CELL GROWTH; CELL TRANSPORT; CHOLESTEATOMA; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEFB2 GENE; DOWN REGULATION; DRUG TARGETING; GENE; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN GENOME; HUMAN TISSUE; KRT6B GENE; LAMC2 GENE; METASTASIS; MICROARRAY ANALYSIS; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PRPH GENE; SIGNAL TRANSDUCTION; SPPR1B GENE; UPREGULATION;

CHOLESTEATOMA, MIDDLE EAR; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; KERATINS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84871445299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052718     Document Type: Article

References (50)

1. Sudhoff H, Stefan Dazert S, Gonzales A, Borkowski G, Park S, et al. (2000) Angiogenesis and Angiogenic Growth Factors in Middle Ear Cholesteatoma. The American Journal of Otology 21: 793-798.
2. Sudhoff H, Tos M, (2007) Pathogenesis of sinus cholesteatoma. Eur Arch Otorhinolaryngol 264: 1137-1143.
3. Wells M, Michaels L, (1991) Mode of growth of aquired cholesteatoma. J Laryngol Otol 105: 261-267.
4. Sudhoff H, Liang J, Dazert S, Borkowski G, Michaels L, (1999) Epidermoid formation on the pathogenesis of congenital cholesteatoma - a current review. Laryngorhinootoligie 78: 63-67.
5. Huisman M, de Heer E, Ten Dijke P, Grote J, (2008) Transforming growth factor beta and wound healing in human cholesteatoma. Laryngoscope 118: 94-98.
6. Shunyu N, Gupta S, Thakar A, Sharma S, (2011) Histological and immunohistochemical study of pars tensa reaction pocket. Otolaryngol Head Neck Surg 45: 628-634.
7. Kwon KH, Kim SJ, Kim HJ, Jung HH (2006) Analysis of gene expression profiles in cholesteatoma using oligonucleotide microarray. Acta Oto-Laryngologica: 691-697.
8. Elek J, Park K, Narayanan R, (2000) Microarray-based expression profiling in prostate tumors. In Vitro 14: 173-182.
9. Yoshikawa M, Kojima H, Wada K, Tsukidate T, Okada N, et al. (2006) Identification of specific gene expression profiles ib fibroblasts derived from middel ear cholesteatoma. Arch Otolaryngol Head and Neck Surg 132: 734-742.
10. Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York. 397-420.
11. Ritchie M, Silver J, Oshlack A, Holmes M, Diyagama D, et al. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics 23: 2700-2707.
12. Smyth G, Speed T, (2003) Normalization of cDNA microarray data. Methods 31: 265-273.
13. Pfaffl M (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29.
14. Janowski s, Kormeier B, Töpel T, Hippe K, Hofestädt R, et al. (2011) Modeling of Cell-to-Cell Communication Processes with Petri Nets Using the Example of Quorum Sensing. Stud Health Technol Inform 162: 182-202.
15. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database - 2009 Update. Nucleic Acids Research 37: D767-D772.
16. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, et al. (2012) The IntAct molecular interaction database in 2012. Nucleic Acids Research 40: D841-D846.
17. Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M, et al. (2011) MINT, the molecular interaction database: 2012 update. Nucleic Acids Research 40: D857-861.
18. Olszewska E, Sudhoff H, (2007) Comperative cytokeratin distribution patterns in cholesteatoma epithelium. Histol Histopathol 22: 37-42.
19. Kim HJ, Tinling S, Chole R, (2002) Expression patterns of cytokertins in cholesteatomas: evidence of increased migration and proliferation. J Korean Med Sci 17: 381-388.
20. Nunes LMA, Barros ALMd, Cal RVR, Nunes CTA, Lima FDd (2010) Giant Cholesteatoma: Case and Literature Review'Report. Int Arch Otorhinolaryngol.
21. Dremmen M, Hofman P, Hof J, Stokroos R, Postma A, (2012) The diagnostic accuracy of non-echo-planar diffusion-weighted imaging in the detection of residual and/or recurrent cholesteatoma of the temporal bone. AJNR Am J Neuroradiol 33: 439-444.
22. Lim D, Saunders W, (1972) Acquired cholesteatoma: light and electron microscopic observations. Ann Otol Rhinol Laryngol 81: 1-11.
23. Dornelles C, Meurer L, Selaimen da Costa S, Schweiger C, (2006) Histologic description of acquired cholesteatomas: comparison between children and adults. Braz J Otorhinolaryngol 72: 641-648.
24. Lee R, Sidey C, Narula A, James R, (1994) The nature of the epithelium in acquired cholesteatoma: part 3-cytokeratins in aural epithelial and cholesteatoma cells grown in cell culture. Clin Otolaryngol 19: 516-520.
25. Kim HJ, Tinling S, Chole R, (2002) Increased proliferation and migration of epithelium in advancing experimental cholesteatomas. Otol Neurotol 23: 840-844.
26. Alam H, Sehgal L, Kundu S, Dalal S, Vaidya M, (2011) Novel function of keratin 5 and 14 in proliferative and differentiation od stratified epithelial cells. Mol Biol Cell 22: 4068-4078.
27. Makiishi-Shimobayashi C, Tsujimura T, Iwasaki T, al e, (2004) Localization of osteopontin at calcification sites of cholesteatoma: possible role as a regulator of deposition of calcium phosphate in the middle ear. AURIS NASUS LARYNX 31: 3-9.
28. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, et al. (2001) The Membran-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis. Cell Press 107: 789-800.
29. Masui T, Doi R, Koshiba T, (2003) RECK Expression in Panreatic Cancer: Its Correlation with Lower Invasiveness and Better Prognosis. Clin Cancer Res 9: 1779-1784.
30. Xu J, Wu S, Xin S, (2010) Expression of Matrix Metalloproteinase Regulator, RECK, and its clinical significance in Osteosarcoma. Journal of Orthopaedic Research 28: 1621-1625.
31. Alam S, Newby D, Henriksen P, (2012) Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury: from epithelium to endothelium. Biochem Pharmacol 83: 695-704.
32. Wei H, Hellström K, Hellström I, (2012) Elafin selectvely regulates the sensitivity of ovarian cancer cells to genotoxic druf-induced apoptosis. Gynecol Oncol 125: 727-733.
33. Li S, Nikulina K, DeVoss J, Wu AJ, Strauss E, et al. (2008) Small Proline-Rich Protein 1B (SPRR1B) Is a Biomarker for Squamous Metaplasia in Dry Eye Disease. Invest Ophthalimol Vis Sci 49: 34-41.
34. Li C, Chan YR, (2011) Lipocalin 2 regulation and its complex role in inflammation and cancer. Cytokine 56: 435-441.
35. Zhang J, Wu Y, Zhang Y, LeRoith D, Bernlohr D, et al. (2008) The Role of Lipocalin 2 in the Regulation of Inflammation in Adipocytes and Macrophages. Molecular Endocrinology 22: 1416-1426.
36. Kojima H, Miyazaki H, Tanaka Y, Shiwa M, Koga T, et al. (1999) Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium. Arch Otolaryngol Head and Neck Surg 125: 735-742.
37. Duxbury M, Ito H, Benoit E, Ashley S, Whang E, (2004) CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. British Journal of Cancer 91: 1384-1390.
38. Blons H, Laccourreye O, Houllier A, Carnot F, Brasnu D, et al. (2002) Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma. Oncogene 21: 5016-5023.
39. Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J (2009) Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostat cancer. BMC Cancer 9.
40. Chen S-S, Claus R, Lucas DM, Yu L, Qian J, et al. (2011) Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood 117: 862-871.
41. Himoudi N, Nabarro S, Yan M, Gilmour K, Thrasher A, et al. (2007) Development of anti-PAX3 immune responses; a target for cancer immunotherapy. Cancer Immunol Immunother 56: 1381-1395.
42. Medic S, Ziman M (2010) PAX3 Expression in Normal Skin Melanocytes and Melanoytic Lesions (Naevi and Melanomas). Plos One 5.
43. Blake J, Ziman M, (2003) Aberrant PAX3 and PA7 expression. A link to the metastatic potential of embryonal rhabdomyocarcoma and cutaneous malignant melanoma. Histol Histopathol 18: 529-539.
44. Jean D, Gershenwald J, Huang S, Luca M, Hudson M, et al. (1998) Loss of AP-2 Results in Up-regulation of MCAM/MUC18 and an Increase in Tumor Growth and Metastasis of Human Melanoma Cells. The Journal of Biological Cemistry 26: 16501-16508.
45. Carter W, Ryan M, Gahr P, (1991) Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membrans. Cell 65: 599-610.
46. Oka T, Yamamoto H, Sasaki S, Ii M, Hizaki K, et al. (2009) Overexpression of β3/γ2 chains of lamminin-5 and MMP7 in biliary cancer. World J Gastroenterol 15: 3865-3875.
47. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S, (2005) Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129: 1375-1385.
48. Lee H, Ciancio S, Tüter G, Ryan M, Komaroff E, et al. (2004) Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J Periodontol 75: 453-463.
49. Hajra K, Featon E, (2002) Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34: 255-268.
50. Chan A, Tsui W, Chen X, Chu K, Chan T, et al. (2003) Downregulation of ID4 by promotor hypermethylation in gastric adenocarcinoma. Oncogene 22: 6946-6953.